SCHEMBL29696456

SCHEMBL29696456

Cc1c(-c2ccc([N+](=O)[O-])cc2)sc2[nH]c(=O)n(-c3cccc(-n4cccn4)n3)c(=O)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC11A2 P49281 1/20 0.38
FLT3 P36888 1/20 0.37
TNKS O95271 4/20 0.35
TNKS2 Q9H2K2 4/20 0.35
PARP1 P09874 2/20 0.35
GNRHR P30968 4/20 0.33
ALDH1A1 P00352 6/20 0.33
POLB P06746 1/20 0.33
PARP2 Q9UGN5 2/20 0.32
HTT P42858 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
ADORA2B P29275 1/20 0.32
GUSB P08236 1/20 0.31
NLRP3 Q96P20 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29696435 0.90 SLC11A2 (0.37) SLC11A2FLT3TNKSTNKS2PARP1
SCHEMBL29696469 0.86 SLC11A2 (0.37) SLC11A2FLT3PARP1GNRHRALDH1A1
SCHEMBL29696450 0.85 SLC11A2 (0.35) SLC11A2FLT3GNRHRALDH1A1HTT
SCHEMBL29696424 0.78 GNRHR (0.57) GNRHR
SCHEMBL29696443 0.78 SLC11A2 (0.37) SLC11A2FLT3GNRHRALDH1A1HTT
SCHEMBL4248933 0.77 ALDH1A1 (0.46) GNRHRALDH1A1POLBHTTMEN1
SCHEMBL29696460 0.77 SLC11A2 (0.37) SLC11A2FLT3GNRHRALDH1A1HTT
SCHEMBL29382466 0.75 APP (0.34) SLC11A2FLT3TNKSTNKS2PARP1
SCHEMBL7202144 0.73 GNRHR (0.46) GNRHRALDH1A1POLBHTTMEN1
SCHEMBL29696377 0.70 GNRHR (0.57) GNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4004001-B1 SUBSTITUTED PYRIMIDINEDIONE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2025-09-03 EP disclosed
US-20220267347-A1 SUBSTITUTED PYRIMIDINEDIONE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-08-25 US disclosed
EP-4004001-A1 SUBSTITUTED PYRIMIDINEDIONE COMPOUNDS AND USES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2022-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220267347-A1 SUBSTITUTED PYRIMIDINEDIONE COMPOUNDS AND USES THEREOF GNRHR, CDK20, PGR SLC11A2 4361/4885FLT3 769/4885TNKS 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.